{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T10:52:57Z","timestamp":1780570377316,"version":"3.54.1"},"update-to":[{"DOI":"10.1002\/14651858.cd005159","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2007,10,17]],"date-time":"2007-10-17T00:00:00Z","timestamp":1192579200000}}],"reference-count":27,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd005159.pub2","type":"journal-article","created":{"date-parts":[[2007,10,10]],"date-time":"2007-10-10T16:19:30Z","timestamp":1192033170000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Rifabutin for treating pulmonary tuberculosis"],"prefix":"10.1002","author":[{"given":"Geraint R","family":"Davies","sequence":"first","affiliation":[{"name":"University of Liverpool; School of Clinical Sciences; Royal Liverpool University Hospital Prescot Street Liverpool Merseyside UK L7 8XP"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Cerri","sequence":"additional","affiliation":[{"name":"Policlinico di Modena, Universita di Modena e Reggio Emilia; Divisione di Pneumologia; Via del Pozzo 71 Modena Italy 41100"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Richeldi","sequence":"additional","affiliation":[{"name":"Policlinico di Modena, Universita di Modena e Reggio Emilia; Divisione di Pneumologia; Via del Pozzo 71 Modena Italy 41100"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,10,17]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD005159.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0962-8479(94)90079-5","article-title":"Rifabutin for the treatment of newly-diagnosed pulmonary tuberculosis: a multinational, randomized, comparative study versus Rifampicin. Rifabutin Study Group","volume":"75","author":"Gonzalez-Montaner","year":"1994","journal-title":"Tubercle and Lung Disease"},{"issue":"1","key":"10.1002\/14651858.CD005159.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0962-8479(92)90081-T","article-title":"A controlled study of rifabutin and an uncontrolled study of ofloxacin in the retreatment of patients with pulmonary tuberculosis resistant to isoniazid, streptomycin and rifampicin. Hong Kong Chest Service\/British Medical Research Council","volume":"73","author":"Hong Kong Chest Service\/British Medical Research Council","year":"1992","journal-title":"Tubercle and Lung Disease"},{"issue":"5","key":"10.1002\/14651858.CD005159.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1164\/ajrccm.154.5.8912765","article-title":"Efficacy and safety of rifabutin in the treatment of patients with newly diagnosed pulmonary tuberculosis","volume":"154","author":"McGregor","year":"1996","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"9-10","key":"10.1002\/14651858.CD005159.pub2-BIB0004|cit4","first-page":"81","article-title":"Preliminary results of rifabutine (ansamycine LM 427) treatment of patients with newly detected and chronic pulmonary tuberculosis and Mycobacterium infections","volume":"60","author":"Rowinska-Zakrzewska","year":"1992","journal-title":"Pneumologia i Alergologia Polska"},{"issue":"3","key":"10.1002\/14651858.CD005159.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0962-8479(05)80007-3","article-title":"A pilot study of antituberculosis combinations comparing rifabutin with rifampicin in the treatment of HIV-1 associated tuberculosis","volume":"76","author":"Schwander","year":"1995","journal-title":"Tubercle and Lung Disease"},{"issue":"3","key":"10.1002\/14651858.CD005159.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1164\/rccm.200503-417OC","article-title":"Acquired rifamycin resistance with twice-weekly treatment of HIV-related tuberculosis","volume":"173","author":"Burman","year":"2006","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"1","key":"10.1002\/14651858.CD005159.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0962-8479(92)90077-W","article-title":"The early bactericidal activity of rifabutin measured by sputum viable counts in Hong Kong patients with pulmonary tuberculosis","volume":"73","author":"Chan","year":"1992","journal-title":"Tubercle and Lung Disease"},{"issue":"6","key":"10.1002\/14651858.CD005159.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/jac\/32.6.867","article-title":"The early bactericidal activity of rifabutin in patients with pulmonary tuberculosis measured by sputum viable counts: a new method of drug assessment","volume":"32","author":"Sirgel","year":"1993","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"5","key":"10.1002\/14651858.CD005159.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2165\/00003088-200140050-00002","article-title":"Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterials","volume":"40","author":"Burman","year":"2001","journal-title":"Clinical Pharmacokinetics"},{"issue":"7","key":"10.1002\/14651858.CD005159.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1469-0691.2004.00917.x","article-title":"In-vitro activity of rifabutin against rifampicin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations","volume":"10","author":"Cavusoglu","year":"2004","journal-title":"Clinical Microbiology and Infection"},{"issue":"9","key":"10.1002\/14651858.CD005159.pub2-BIB0011|cit11","first-page":"185","article-title":"Updated guidelines for the use of rifabutin or rifampin for the treatment and prevention of tuberculosis among HIV-infected patients taking protease inhibitors or non-nucleoside reverse transcriptase inhibitors","volume":"49","author":"Centers for Disease Control and Prevention","year":"2000","journal-title":"Morbidity and Mortality Weekly Reports"},{"issue":"4 Pt 1","key":"10.1002\/14651858.CD005159.pub2-BIB0012|cit12","first-page":"367","article-title":"Experimental models to explain the high sterilizing activity of rifampicin in the chemotherapy of tuberculosis","volume":"123","author":"Dickinson","year":"1981","journal-title":"American Review of Respiratory Diseases"},{"issue":"7","key":"10.1002\/14651858.CD005159.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jama.282.7.677","article-title":"Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project","volume":"282","author":"Dye","year":"1999","journal-title":"JAMA"},{"issue":"14","key":"10.1002\/14651858.CD005159.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"8180","DOI":"10.1073\/pnas.140102797","article-title":"Criteria for the control of drug-resistant tuberculosis","volume":"97","author":"Dye","year":"2000","journal-title":"Proceedings of the National Academy of Sciences USA"},{"issue":"10 Suppl 2","key":"10.1002\/14651858.CD005159.pub2-BIB0015|cit15","first-page":"231","article-title":"Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946-1986, with relevant subsequent publications","volume":"3","author":"Fox","year":"2001","journal-title":"International Journal of Tubercle and Lung Disease"},{"issue":"2","key":"10.1002\/14651858.CD005159.pub2-BIB0016|cit16","doi-asserted-by":"publisher","DOI":"10.1002\/14651858","article-title":"Regimens of less than six months for treating tuberculosis","author":"Gelband","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005159.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/clinids\/22.Supplement_1.S50","article-title":"Use of rifabutin in the treatment of pulmonary tuberculosis","volume":"22 Suppl 1","author":"Grassi","year":"1996","journal-title":"Clinical Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD005159.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1164\/ajrccm\/137.3.719","article-title":"Rifabutin: minimal inhibitory and bactericidal concentrations for Mycobacterium tuberculosis","volume":"137","author":"Heifets","year":"1988","journal-title":"American Review of Respiratory Diseases"},{"key":"10.1002\/14651858.CD005159.pub2-BIB0019|cit19","unstructured":"Higgins J Green S Highly sensitive search strategies for identifying reports of randomized controlled trials in MEDLINE. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]; Appendix 5b www.cochrane.org\/resources\/handbook\/hbook.htm"},{"issue":"6 Pt 1","key":"10.1002\/14651858.CD005159.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1164\/ajrccm\/148.6_Pt_1.1541","article-title":"Effectiveness of rifampicin, rifabutin and rifapentine for preventive therapy of mouse tuberculosis in mice","volume":"148","author":"Ji","year":"1993","journal-title":"American Review of Respiratory Disease"},{"issue":"7303","key":"10.1002\/14651858.CD005159.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bmj.323.7303.42","article-title":"Systematic reviews in health care: Assessing the quality of controlled clinical trials","volume":"323","author":"Juni","year":"2001","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD005159.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/clinids\/22.Supplement_1.S3","article-title":"Antimicrobial activity of rifabutin","volume":"22 Suppl 1","author":"Kunin","year":"1996","journal-title":"Clinical Infectious Diseases"},{"issue":"8","key":"10.1002\/14651858.CD005159.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.7164\/antibiotics.34.1033","article-title":"New rifamycins modified at positions 3 and 4: synthesis, structure and biological evaluation","volume":"34","author":"Marsili","year":"1981","journal-title":"Journal of Antibiotics (Tokyo)"},{"issue":"5","key":"10.1002\/14651858.CD005159.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/jac\/29.5.477","article-title":"Understanding the chemotherapy of tuberculosis: current problems","volume":"29","author":"Mitchison","year":"1992","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"3","key":"10.1002\/14651858.CD005159.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/clinids\/9.3.519","article-title":"Rifabutin (Ansamycin LM 427): A new rifamycin-S derivative for the treatment of mycobacterial diseases","volume":"9","author":"O'Brien","year":"1987","journal-title":"Reviews of Infectious Diseases"},{"key":"10.1002\/14651858.CD005159.pub2-BIB0026|cit26","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2003"},{"issue":"3","key":"10.1002\/14651858.CD005159.pub2-BIB0027|cit27","first-page":"211","article-title":"Activity of the spiropiperidyl rifamycin LM 427 on rifampicin resistant Mycobacterium tuberculosis","volume":"31","author":"Ungheri","year":"1984","journal-title":"Giornale Italiano di Chemioterapia"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD005159.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T21:45:41Z","timestamp":1628545541000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD005159.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Infectious Diseases Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2007,10,17]]},"references-count":27,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005159.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,17]]}}}